Crystal-associated arthritis in the elderly

Rheumatic Disease Clinics of North America

Volumn 26, Issue 3, 2000, Pages 527-546

  Agudelo, Carlos A ^a,b   Wise, Christopher M ^c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; CALCIUM OXALATE; CALCIUM PHOSPHATE; COLCHICINE; CORTICOSTEROID; HYDROXYAPATITE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; URICOSURIC AGENT;

ARTHRITIS; CHONDROCALCINOSIS; CLINICAL FEATURE; CRYSTAL; DIFFERENTIAL DIAGNOSIS; GOUT; PRIORITY JOURNAL; PSEUDOGOUT; REVIEW; SEX DIFFERENCE;

EID: 0033845323     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70155-1     Document Type: Article

References (64)

1. Gout and coronary artery disease: The Framingham study
2. Crystal deposition diseases
3. Definitive diagnosis of gout by identification of urate crystals in asymptomatic metatarsophalangeal joints
4. Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis
5. Colchicine prophylaxis in pseudogout
6. Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout
7. The role of lead in gout nephropathy
8. Pseudogout mimicking systemic disease
9. Intermittent control of hyperuricemia in the treatment of gout
10. Asymptomatic hyperuricemia: Risks and consequences in the Normative Aging Study
11. Crystal deposition in the elderly
12. The management of gout
13. Current therapy of acute microcrystalline arthritis and the role of corticosteroids
14. Gout in the elderly: Clinical presentation and treatment
15. Gouty arthritis in nodal osteoarthritis
16. Arthritis in hemochromatosis
17. Optimal management of gout in older persons
18. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons
19. Systemic steroid therapy for acute gout
20. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old
21. Thiazide diuretics and the initiation of anti-gout therapy
22. Acute polyarticular gout
23. Milwaukee shoulder syndrome: Fifteen additional cases and a description of contributing factors
24. Severe allopurinol toxicity: Description and guide-lines for prevention in patients with renal insufficiency
25. COX-2 inhibitors
26. Gout and pseudogout in hospitalized patients
27. Racial differences in the incidence of gout
28. Finger pad tophi in gout
29. Gout and hyperuricemia
30. Colchicine myopathy and neuropathy
31. Urate-mediated inflammation in nodal osteoarthritis: Clinical and roentgenographic correlations
32. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
33. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States
34. Polyarticular versus monoarticular gout: A prospective comparative analysis of clinical features
35. Diuretic-induced gout in elderly women
36. Diagnostic mimicry in arthritis: Patterns of joint involvement associated with calcium pyrophosphate dihydrate crystals
37. Identification of urate crystals in gouty synovial fluids
38. The significance of calcium phosphate crystals in the synovial fluid of arthritis patients: The 'pseudogout syndrome': I. Clinical aspects
39. Milwaukee shoulder: Association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects: I. Clinical aspects
40. Common rheumatologic diseases in the elderly
41. Tophaceous gout: A clinical and radiographic assessment
42. Treatment of chronic gout in patients with renal function impairment: An open, randomized, actively controlled study
43. Female gout: Clinical spectrum and uric acid metabolism
44. Acute polyarticular gout
45. Diseases associated with deposition of calcium pyrophosphate or hydroxyapatite
46. ACTH revisited: Effective treatment for acute crystal induced synovitis in patients with multiple medical problems
47. Prospective use of intramuscular triamcinolone acetonide in pseudogout
48. Colchicine in acute gout: Reassessment of risks and benefits
49. Prospective 6-month double blind trial of hydroxychloroquine treatment of CPPD
50. Gout and hyperuricemia
51. The role of crystals in osteoarthritis
52. Hemochromatosis and arthritis
53. Diuretic induced gout: A multifactorial condition
54. Misdiagnosis of rheumatoid arthritis in an elderly woman with gout
55. Tophaceous deposition in the finger pads without gouty arthritis
56. Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis
57. Gout in Heberden's nodes
58. Arthropathy as the presenting symptom in hereditary hemochromatosis
59. Gout in the elderly, a separate entity?
60. Systemic toxicity associated with the intravenous administration of colchicine: Guidelines for use
61. Renal function predicts colchicine toxicity: Guidelines for the prophylactic use of colchicine in gout
62. Tophi as the initial manifestation of gout: Report of six cases and review of the literature
63. Osteoarthritis and articular chondrocalcinosis in the elderly